Moleculin Biotech Stock Price on December 26, 2023
| MBRX Stock | USD 2.77 0.08 2.97% |
Below is the normalized historical share price chart for Moleculin Biotech extending back to June 02, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Moleculin Biotech stands at 2.77, as last reported on the 30th of November, with the highest price reaching 2.77 and the lowest price hitting 2.59 during the day.
If you're considering investing in Moleculin Stock, it is important to understand the factors that can impact its price. Moleculin Biotech appears to be risky, given 3 months investment horizon. Moleculin Biotech has Sharpe Ratio of 0.059, which conveys that the firm had a 0.059% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Moleculin Biotech, which you can use to evaluate the volatility of the firm. Please exercise Moleculin Biotech's Risk Adjusted Performance of 0.0493, downside deviation of 4.64, and Mean Deviation of 3.76 to check out if our risk estimates are consistent with your expectations.
At this time, Moleculin Biotech's Total Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to about 83.3 K in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 1.6 M in 2024. . At this time, Moleculin Biotech's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.02 in 2024, whereas Price Earnings Ratio is likely to drop (0.90) in 2024. Moleculin Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of June 2016 | 200 Day MA 3.1225 | 50 Day MA 2.5575 | Beta 1.858 |
Moleculin |
Sharpe Ratio = 0.059
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MBRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.63 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Moleculin Biotech is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Moleculin Biotech by adding it to a well-diversified portfolio.
Price Book 1.1118 | Book Value 3.358 | Enterprise Value -699.8 K | Enterprise Value Ebitda 0.5229 | Shares Float 2.7 M |
Related Headline
Cyclacel Pharmaceuticals Headline on 26th of December 2023
Purchase by Spiro Rombotis of 6070 shares of Cyclacel Pharma... by Spiro Rombotis
Filed transaction by Cyclacel Pharmaceuticals director. General open market or private purchase of non-derivative or derivative security
Moleculin Biotech Valuation on December 26, 2023
It is possible to determine the worth of Moleculin Biotech on a given historical date. On December 26, 2023 Moleculin was worth 9.75 at the beginning of the trading date compared to the closed value of 9.72. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Moleculin Biotech stock. Still, in general, we apply an absolute valuation method to find Moleculin Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Moleculin Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Moleculin Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 9.90 | 10.35 | 9.90 | 10.20 | 4,484 | |
12/26/2023 | 9.75 | 10.16 | 9.30 | 9.72 | 8,569 |
| 10.20 | 11.25 | 10.00 | 10.65 | 49,594 |
| Backtest Moleculin Biotech | | | Moleculin Biotech History | | | Moleculin Biotech Valuation | Previous | Next |
Moleculin Biotech Trading Date Momentum on December 26, 2023
| On December 27 2023 Moleculin Biotech was traded for 10.65 at the closing time. The top price for the day was 11.25 and the lowest listed price was 10.00 . The trading volume for the day was 49.6 K. The trading history from December 27, 2023 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 9.57% . The trading delta at closing time against the current closing price is 37.45% . |
Moleculin Biotech Fundamentals Correlations and Trends
By evaluating Moleculin Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Moleculin Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Moleculin financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Moleculin Biotech Stock history
Moleculin Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Moleculin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Moleculin Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Moleculin Biotech stock prices may prove useful in developing a viable investing in Moleculin Biotech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2 M | 1.6 M | |
| Net Loss | -14.3 M | -15 M |
Moleculin Biotech Quarterly Net Working Capital |
|
Moleculin Biotech Stock Technical Analysis
Moleculin Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Moleculin Biotech Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Moleculin Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Moleculin Biotech November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Moleculin Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Moleculin Biotech shares will generate the highest return on investment. By undertsting and applying Moleculin Biotech stock market strength indicators, traders can identify Moleculin Biotech entry and exit signals to maximize returns
Moleculin Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Moleculin Biotech's price direction in advance. Along with the technical and fundamental analysis of Moleculin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Moleculin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0493 | |||
| Jensen Alpha | 0.3452 | |||
| Total Risk Alpha | (0.64) | |||
| Sortino Ratio | 0.0336 | |||
| Treynor Ratio | (0.59) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Moleculin Stock Analysis
When running Moleculin Biotech's price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.